Robbins K T, Fuller L M, Vlasak M, Osborne B, Jing B S, Velasquez W S, Sullivan J A
Cancer. 1985 Aug 15;56(4):814-9. doi: 10.1002/1097-0142(19850815)56:4<814::aid-cncr2820560419>3.0.co;2-p.
Extranodal lymphomas which present in the nasal cavity and/or the paranasal sinuses are rare. Thirty-eight patients with disease that was clinically limited to the head and neck (Ann Arbor Stages IE-IIE) were admitted between 1947 and 1983. Twenty-eight patients were treated with radiotherapy alone and 10 received combination chemotherapy in addition. The overall 5-year survival figure was 56%. The corresponding result for Stage IE was 67%. No patient with Stage IIE disease survived 5 years. Extent of the extranodal disease also influenced results for Stage IE patients who were treated with radiotherapy only. When the extranodal disease was staged using the American Joint Committee TNM system, the 5-year disease-free survival for T1 and T2 patients was 78% as compared with 19% for patients with T3 and T4 disease. The addition of combination chemotherapy improved results for patients with T3 and T4 lesions.
发生于鼻腔和/或鼻窦的结外淋巴瘤较为罕见。1947年至1983年间收治了38例临床局限于头颈部(Ann Arbor分期IE-IIE期)的患者。28例患者仅接受放疗,10例还接受了联合化疗。总体5年生存率为56%。IE期的相应结果为67%。没有IIE期患者存活5年。结外病变范围也影响了仅接受放疗的IE期患者的治疗结果。当使用美国联合委员会TNM系统对结外病变进行分期时,T1和T2期患者的5年无病生存率为78%,而T3和T4期患者为19%。联合化疗的加入改善了T3和T4期病变患者的治疗结果。